Paired Associative Stimulation (PAS) for Stroke Rehabilitation
Condition(s) studied
Investigational drug(s) / intervention(s)
A multi-channel device with deep TMS coil (Brainsway Ltd., Jerusalem, Israel): Active dTMS-PAS stimulation is applied at 120% of the individual RMT of the UH. Each session consists of 600 paired pulses, delivered bilaterally over M1-M1, with an inter-pulse interval (IPI) of 10 miliseconds (ms) and an inter-stimulus interval (ISI) of 3 seconds (s), for a total duration of 30 minutes (m).
A multi-channel device with deep TMS coil (Brainsway Ltd., Jerusalem, Israel): Sham PAS is delivered using the same coil, applied at 40% of the individual RMT of the UH. Each session consists of identical number of paired pulses and timing parameters as in the Active PAS arm, but at an intensity insufficient to induce cortical modulation.
Study summary
Paired associative stimulation (PAS) delivered with multi-channel deep transcranial magnetic stimulation (dTMS) may enhance motor recovery in patients with first-ever ischemic stroke. This study evaluates whether dTMS-PAS targeting both primary motor cortices (M1-M1) improves upper-extremity hemiparesis when administered at the early subacute stage (up to three weeks poststroke).
Eligibility
Primary outcome measure(s)
- Fugl - Meyer Assessment for Upper Extremity (FMA-UE) Score — From enrollment to one year after enrollment
The FMA-UE is a standardized, clinical, stroke-specific performance scale assessing motor impairement of the upper-extremity. It includes 33 items across four domains (shoulder-arm, wrist, hand, coordination), each scored 0-2 (total range 0-66). Higher scores indicate better motor function. Assessment Schedule: Pre-treatment (up to three weeks poststroke), Post-treatment (three weeks consisting of 15 sessions), 1 and 2 months post-treatment, and 6,9, and 12 months poststroke.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Soroke University Medical Center | Beersheba | Israel |
More Soroka University Medical Center trials in Israel
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07691099 on ClinicalTrials.gov ↗ ← All trials in Israel